Latest Regulatory Milestones News

National Australia Bank’s June quarter saw a slight dip in cash earnings due to rising credit impairment charges, even as underlying profits edged up 2%. The bank balances cautious asset quality management with ongoing growth in lending and deposits.

Alice Queen Limited has formally lodged a 15-year mining lease application for its Horn Island Gold Project, marking a significant step forward in its decade-long exploration journey and attracting strong partnership interest.

Laramide Resources has made significant progress in advancing its uranium projects across the US, Australia, and Kazakhstan, highlighted by key permitting milestones under the US FAST-41 framework and a successful $12 million private placement to fund development.

Laramide Resources Ltd. reported a reduced net loss of CAD 1.05 million for H1 2025, converting USD 3.5 million of debt into equity and securing a $12 million private placement to bolster its uranium exploration projects.

Lunnon Metals has reported robust metallurgical test results for its Lady Herial gold deposit, confirming strong gold grades and recoveries that align with recent economic studies. These findings bolster the project’s development prospects amid ongoing negotiations with Gold Fields.

Euro Manganese Inc. has bolstered its development of the Chvaletice Manganese Project with new financing and critical regulatory approvals, while progressing offtake discussions amid ongoing market uncertainties.

The Tanzanian Mining Commission has granted consent for Shenghe Resources to acquire all remaining shares in Peak Rare Earths, advancing a major consolidation in the rare earths sector. The deal still awaits shareholder and regulatory approvals before completion.

Peninsula Energy has secured regulatory approval to begin Phase 2 feeding at its Lance Project’s Central Processing Plant, moving closer to commercial uranium production. The company also welcomes seasoned executive Keith Bowes to its board as it prepares for a capital raise.

Green Technology Metals has achieved a major regulatory milestone by securing full mining lease coverage for its Seymour Lithium Project in Ontario, significantly advancing the project toward construction readiness.

Anteris Technologies reported solid clinical progress with 130 patients implanted with its DurAVR heart valve and is gearing up for its pivotal PARADIGM trial with 79 qualified sites worldwide. The company also strengthened its leadership with two new board members amid ongoing FDA engagement.

Anteris Technologies Global Corp. reported a $42.7 million net loss for the first half of 2025 amid advancing preparations for its pivotal DurAVR Transcatheter Heart Valve trial. The company’s recent IPO proceeds are fueling R&D and manufacturing scale-up as it targets regulatory approvals.

Island Pharmaceuticals has raised $350,000 through an options exercise by substantial shareholder MWP Partners, reinforcing confidence in its antiviral drug development pipeline.